ORIGINAL CONTRIBUTION. Diagnostic Accuracy of Dementia With Lewy Bodies. to be the second

Size: px
Start display at page:

Download "ORIGINAL CONTRIBUTION. Diagnostic Accuracy of Dementia With Lewy Bodies. to be the second"

Transcription

1 ORIGINAL CONTRIBUTION Diagnostic Accuracy of Dementia With Lewy Bodies Ursula Hohl, MD; Pietro Tiraboschi, MD; Lawrence A. Hansen, MD; Leon J. Thal, MD; Jody Corey-Bloom, MD, PhD Background: Diagnostic criteria for dementia with Lewy bodies (DLB) are still evolving. No data exist on prospective differentiation of DLB and Alzheimer disease (AD). Objective: To examine the clinician s diagnostic accuracy for DLB and analyze factors contributing to falsepositive DLB diagnoses. Methods: A prospective series of 10 patients with clinically diagnosed DLB who came to autopsy was compared with 32 autopsy-confirmed cases of DLB (27 Lewy body variant, 5 diffuse Lewy body disease) and 20 autopsyconfirmed cases of AD (matched on age, sex, education, and initial Mini-Mental State Examination score) with regard to distinguishing and/or confounding clinical features. Results: The clinical diagnostic accuracy for DLB was 50%, with 5 of the 10 patients clinically presumed to have DLB confirmed at autopsy. Of the 5 misdiagnosed cases, 4 had AD and 1 had progressive supranuclear palsy. The misdiagnosed DLB cases who had pure AD had fewer hallucinations (25%) than those with Lewy body variant (63%) or diffuse Lewy body disease (100%) (P =.048); however, an equal amount of spontaneous (in the absence of neuroleptics) extrapyramidal signs was found. There were no differences among groups with regard to daily fluctuations in cognition or falls. Compared with the AD control group, the misdiagnosed DLB cases with pure AD showed significantly more spontaneous extrapyramidal signs (P.02). Conclusions: The clinician s diagnostic accuracy for DLB was poor. Early spontaneous extrapyramidal signs in AD were associated with false-positive clinical diagnoses of DLB. The distinction between DLB and AD may be improved by greater emphasis on hallucinations. Arch Neurol. 2000;57: From the Department of Neurosciences, University of California, San Diego, La Jolla, Calif (Drs Hohl, Hansen, Thal, and Corey-Bloom); Neurology Service, Veterans Affairs Medical Center, San Diego, Calif (Drs Hohl, Thal, and Corey-Bloom); and Neurologia Prima, Ospedali Riuniti, Bergamo, Italy (Dr Tiraboschi). DEMENTIA WITH Lewy bodies (DLB) 1 has been reported to be the second most common neuropathological cause of dementia, after Alzheimer disease (AD). 2 Nosologically, this is a very complex area that includes such entities as the Lewy body variant (LBV) of AD, 3 diffuse Lewy body disease (DLBD), 4 and senile dementia of Lewy body type, 5 among others. However, despite variable nomenclatures, most of these patients are found at autopsy to have an admixture of AD and parkinsonian pathologic findings, including senile plaques as well as brainstem and cortical Lewy bodies. Clinically, extrapyramidal signs (EPSs), including bradykinesia and rigidity, but not resting tremor, are common findings in DLB. Often, EPSs appear early in the course of illness and help to distinguish this entity from pure AD. Many patients also have prominent psychiatric features (especially visual hallucinations) and a fluctuating level of consciousness in addition to a history of falls. 5,6 Although many of these features overlap to some extent with AD, several studies have reported a sufficiently distinctive clinical pattern to distinguish DLB from AD. 7,8 Others 9-11 find that the clinical distinction between AD and DLB is more subtle. However, all of these studies were performed retrospectively by review of clinical records or databases. No study, to our knowledge, has attempted to prospectively evaluate the accuracy of the clinical diagnosis of DLB. While neuropathological series demonstrate high accuracy for the clinical diagnosis of AD, 12 the accuracy of the clinical diagnosis of DLB remains less clear. One study focusing on differentiating DLB and Parkinson disease from each other and from other parkinsonian disorders reported that DLB was underdiagnosed and mostly misdiagnosed as Parkinson dis- 347

2 PATIENTS AND METHODS PATIENTS Approximately 120 subjects who were followed up at the Alzheimer s Disease Research Center at the University of California, San Diego, came to autopsy between 1990 and Ten patients had received the clinical diagnosis of DLB. Except for 1 patient, all had been examined on an annual basis (mean follow-up, 4 years; range, 2-8 years), with a standardized evaluation including history, psychiatric symptoms (assessed by the Diagnostic Interview Schedule), complete neuropsychological assessment, medical and neurologic examinations, and laboratory testing. Neurologists experienced in the assessment of AD and Parkinson disease had performed the neurologic evaluations and determined the clinical diagnoses. In this series of DLB, we did not include patients with Parkinson disease and dementia to whom the term DLB could potentially apply. NEUROPATHOLOGICAL EXAMINATION All autopsies were performed by one of us (L.A.H.) according to a standardized protocol. 3 Tissue blocks from the neocortex, hippocampus, brainstem, cerebellum, and subcortical areas were stained with hematoxylin, eosin, and thioflavin. Senile plaques and lesion counts for senile plaques and neurofibrillary tangles were quantified. When Lewy bodies were identified in the pigmented nuclei of the brainstem, the neocortex was examined for Lewy bodies and their presence was confirmed with antiubiquitin immunocytochemical analysis. The pathological diagnosis of LBV was made when the brain showed Lewy bodies in cortical and subcortical areas and sufficient plaques to meet National Institute on Aging criteria 17 and criteria of the Consortium to Establish a Registry for Alzheimer s Disease for definite or probable AD. 18 The pathological diagnosis of DLBD required cortical and subcortical Lewy bodies without significant AD lesions. All the LBV and DLB cases met the Consortium on Dementia With Lewy Bodies criteria for a pathological diagnosis of DLB. 1 DIAGNOSTIC ACCURACY To determine the accuracy of the clinical diagnosis of DLB, we used the last recorded diagnosis for each patient and compared it with the subject s pathological diagnosis. Except for 1 individual, all patients had died within 1 year of the last clinical diagnosis of DLB. The clinical diagnostic accuracy was defined as (true positive)/(true positive + false positive). CLINICAL COMPARISON To examine which factors may have contributed to the clinical misdiagnosis of DLB, we compared the subjects misdiagnosed as having DLB (who had AD pathologic findings only) with clinical features of all patients with autopsyproved LBV (n = 27) and DLBD (n = 5) who had come to autopsy at our center. Next, we compared the clinical characteristics of these subjects misdiagnosed as having DLB with those of a group of 20 patients with autopsy-proved AD. The latter were carefully matched on the basis of age, sex, education, and initial Mini-Mental State Examination (MMSE) score. 19 The comparison of clinical characteristics included the presence or absence of spontaneous (no neuroleptic usage) EPSs, including masked facies, bradykinesia, and rigidity (without regard to their severity); tremor (resting and postural); gait abnormalities (unsteady gait, parkinsonian gait); hallucinations (visual and/or auditory); falls; and daily fluctuations in cognition. Information concerning falls, loss of consciousness, syncope, and daily fluctuations was obtained from the initial and annual history provided by the patients caregivers. Additional evidence of fluctuation was sought in the Hachinski ischemic scale. 20 STATISTICAL ANALYSIS Demographic variables and MMSE scores were compared by means of a Student t test; the frequencies of neurologic signs or symptoms and hallucinations were compared by Fisher exact test. Data are presented as means and SDs. ease or AD. 13 It is of particular interest to distinguish between AD and DLB during life, because patients with DLB may show faster disease progression, 14 appear to respond differently to acetylcholinesterase inhibitors, 15 and may be abnormally sensitive to standard neuroleptic medications. 16 In particular, clinical trials of acetylcholinesterase inhibitors and other agents may be confounded by patient heterogeneity, which may impede our ability to evaluate their effectiveness. The purpose of the present study was to examine prospectively the accuracy of the clinical diagnosis of DLB and to examine factors that may have confounded the diagnosis by comparing the clinically misdiagnosed subjects with well-defined cohorts of autopsy-proved AD and DLB. RESULTS The clinical diagnostic accuracy for DLB was 50%. In only 5 of the 10 patients clinically presumed to have DLB was the diagnosis confirmed at autopsy. Of the 5 misdiagnosed subjects, 4 were found to have pathologic findings of AD at autopsy and 1 met pathological criteria for progressive supranuclear palsy. Table 1 lists clinical and pathological diagnosis, sex, age at initial examination, interval from first visit to death, and the initial and last MMSE scores of the 10 patients with clinically presumed DLB. SUMMARY OF CASE HISTORIES Patient 1 was reported to become delusional at an MMSE score of 18. He developed spontaneous bradykinesia and a shuffling gait at an MMSE score of 15 and subsequently suffered a collapse. Patient 2 manifested mild bradykinesia at an MMSE score of 22 and demonstrated rigidity, tremor, and a shuffling gait at an MMSE score of 6 in the absence of neuroleptic medication. Patient 3, receiving a low as-needed dose of haloperidol (0.5 mg), manifested bradykinesia, cogwheeling, and visual hal- 348

3 Table 1. Characteristics of Patients Clinically Diagnosed as Having Dementia With Lewy Bodies* Patient No./Sex/ Age, y Initial MMSE Score Final Interval to Death, y lucinations at an MMSE score of 14. Patient 4 exhibited tremor and an unsteady gait at initial examination, with an MMSE score of 20. One year later, still at a score of 20 on the MMSE, he developed spontaneous rigidity, parkinsonian gait, masked facies, and bradykinesia. Patient 5 had dysarthria at an MMSE score of 23. The following year he showed spontaneous rigidity, hypophonia, masked facies, and bradykinesia with an MMSE score of 13. In patient 6, spontaneous mild bradykinesia was noted at first visit (MMSE score, 18). After 2 years the patient progressed to an MMSE score of 2 and was found to have visual and auditory hallucinations, masked facies, parkinsonian gait, and tremor. Patient 7 had postural instability at an MMSE score of 23. The following year, with an MMSE score of 17, he displayed spontaneous EPSs with masked facies, cogwheeling, bradykinesia, and visual hallucinations. Patient 8 exhibited spontaneous rigidity at his first visit (MMSE score, 20), with subsequent hypophonic speech, bradykinesia, and parkinsonian gait, all in the absence of neuroleptic medication. At an MMSE score of 3, the patient developed visual hallucinations. Patient 9 manifested spontaneous hypophonic speech, masked facies, bradykinesia, cogwheeling, tremor, and visual hallucinations at an MMSE score of 22. Patient 10 was suspected of having visual hallucinations at his first visit, with an MMSE score of 21. Two years later, at an MMSE score of 15, he developed spontaneous EPSs with parkinsonian gait, masked facies, and bradykinesia, in addition to visual hallucinations. Fluctuation in cognition was not described in any of these subjects. ADDITIONAL RESULTS Pathological Diagnosis 1/F/ AD 2/F/ AD 3/F/81 14 Untestable 2 AD 4/M/ AD 5/M/ PSP 6/F/ LBV 7/M/ DLBD 8/M/ LBV 9/F/ DLBD 10/M/ LBV *MMSE indicates Mini-Mental State Examination; AD, Alzheimer disease; PSP, progressive supranuclear palsy; LBV, Lewy body variant; and DLBD, diffuse Lewy body disease. Age at initial examination. We further contrasted the patients clinically misdiagnosed as having DLB (who had AD pathologic findings only) with clinical features of all patients with LBV (n = 27) and DLBD (n = 5) who had been examined and came to autopsy through our center. Demographic features and clinical characteristics of these cohorts are shown in Table 2 and Table 3, respectively. In general, patients with DLBD had significantly higher MMSE scores Table 2. Demographics of Patient Groups* DLBD (n=5) LBV (n = 27) Misdiagnosed DLB Having Pure AD (n=4) AD (n = 20) Sex, No. F/M 1:4 10:17 3:1 15:5 Age at first visit, y 73.4 ± ± ± ± 6.4 Education, y 15.4 ± ± ± ± 3.1 MMSE at first visit 23.0 ± ± ± ± 5.6 Interval to death, y 2.4 ± ± ± ± 3.0 *DLBD indicates diffuse Lewy body disease; LBV, Lewy body variant of Alzheimer disease; DLB, dementia with Lewy bodies; AD, Alzheimer disease; and MMSE, Mini-Mental State Examination. P =.046, misdiagnosed DLB vs DLBD. Table 3. Clinical Characteristics of Patient Groups* DLBD (n=5) LBV (n = 27) Misdiagnosed DLB Having Pure AD (n=4) AD (n = 20) Hallucinations No. (%) of patients 5 (100) 17 (63) 1 (25) 2 (10) Mean MMSE score 21.4 ± ± ± 1.0 Falls No. (%) of patients 1 (20) 9 (33) 1 (25) 5 (25) Mean MMSE score ± ± 9.7 Fluctuations No. (%) of patients 0 10 (37) 0 4 (20) Mean MMSE score NA 16.8 ± 7.8 NA 19.5 ± 5.0 Essential tremor No. (%) of patients 4 (80) 16 (59) 2 (50) 8 (40) Mean MMSE score 22.5 ± ± ± ± 8.9 Bradykinesia No. (%) of patients 3 (75) 13 (65) 3 (100) 3 (19) Mean MMSE score 20.7 ± ± ± ± 8.9 Rigidity No. (%) of patients 3 (75) 6 (30) 2 (67) 3 (19) Mean MMSE score 20.0 ± ± ± ± 7.4 Masked facies No. (%) of patients 3 (75) 11 (55) 2 (67) 0 Mean MMSE score 20.7 ± ± ± 9.9 NA Gait disorder No. (%) of patients 3 (75) 10 (50) 3 (100) 2 (13) Mean MMSE score 20.7 ± ± ± ± 15.6 Neuroleptic exposure No. (%) of patients 2 (40) 18 (65) 3 (75) 13 (65) Mean MMSE score 16.5 ± ± ± ± 7.5 *DLBD indicates diffuse Lewy body disease; LBV, Lewy body variant of Alzheimer disease; DLB, dementia with Lewy bodies; AD, Alzheimer disease; and MMSE, Mini-Mental State Examination (mean score at which feature appeared is given); and NA, not applicable. P.05, misdiagnosed DLB having pure AD vs DLBD. Falls include loss of consciousness and syncope. Comparisons were restricted to neuroleptic-naive patients: 4 in the DLBD group, 20 with LBV, 3 in the misdiagnosed DLB group, and 16 in the AD group. P.05, misdiagnosed DLB having pure AD vs matched subjects with AD. Refers to exposure to neuroleptics at any point in the course of the illness. at initial examination but shorter intervals to death than the other cohorts. Hallucinations were more prevalent in the LBV (63%) and especially in the DLBD (100%, P =.048) groups than in the misdiagnosed DLB cases with pure AD. No statistically significant differences were seen with regard to falls, loss of consciousness, or syncope 349

4 among the cohorts. Fluctuations in cognition, although without statistically significant differences across the cohorts, were only reported in patients with LBV. Essential tremor was not a distinguishing feature, as it occurred in 59% of the LBV, 80% of the DLBD, and 50% of the misdiagnosed DLB groups. Comparisons of EPSs were undertaken only with neuroleptic-naive subjects. Although the differences were not statistically significant, the clinically misdiagnosed DLB cases with pure AD pathologic findings had the highest prevalence of bradykinesia and gait disturbances of all 3 groups. Spontaneous parkinsonian gait occurred in 100% of the patients with misdiagnosed DLB who had pure AD pathologic findings, and only 50% of the patients with autopsy-proved LBV and 75% of those with autopsy-proved DLBD. There were also no statistically significant differences with regard to rigidity and masked facies across the cohorts. Finally, we compared the clinical characteristics of the patients with clinically misdiagnosed DLB who had pure AD pathologic findings with those of a group of 20 patients with autopsy-proved AD, carefully matched on the basis of age at initial examination, sex, education, and initial MMSE score. There were no statistically significant differences with regard to prevalence of hallucinations, falls, cognitive fluctuations, or tremor. However, the clinically misdiagnosed DLB cases with pure AD pathologic findings showed a significantly higher prevalence of bradykinesia (P =.02), masked facies (P =.02), and gait disorder (P =.01). COMMENT The results of this study demonstrate that the diagnostic accuracy for DLB is poor. Dementia with Lewy bodies was confirmed at autopsy in only 50% of subjects in our series with a clinical diagnosis of DLB. The majority of the cases of clinically misdiagnosed DLB had pure AD pathologic findings. A comparison of these misdiagnosed cases with clinical features of our autopsy-proved DLBD, LBV, and carefully matched AD cases showed that the patients who were overcalled clinically as having DLB generally had spontaneous EPSs, despite an absence of hallucinations, at mild to moderately demented stages of disease. By moderate stages of dementia, EPSs are fairly prevalent even in pure AD ; thus, in the absence of hallucinations, EPSs at this stage, even in neuroleptic-naive patients, fail to distinguish DLB from AD. Dementia with Lewy bodies has only recently emerged as a clinical entity. Its criteria are still evolving. The 1996 consensus guidelines for DLB were not operational during most of this study. 1 Retrospectively, only one of the clinically misdiagnosed DLB cases would have met criteria for probable DLB, while the other 4 would have met criteria only for possible DLB. In contrast, all of the patients with correctly diagnosed DLB would have met criteria for probable DLB according to consensus guidelines. Extrapyramidal signs have been reported to occur earlier and to be more common in patients with DLB than AD. 3,21 However, other investigators have found no difference with regard to spontaneous EPSs between AD and DLB 10 or have reported that, although EPSs occurred more frequently in DLB, they were not detected in more than 50% of cases of DLB. 9,22 Clinical case series suggest that spontaneous EPSs occur in patients with AD with mild to moderate dementia with a prevalence of 29% to 40%. 23,24 Although the erroneous inclusion of cases with DLB in these studies may have accounted for this relatively high prevalence of EPSs, our results suggest that there is a subgroup of patients with AD who display EPSs at a relatively early stage and who may not be distinguishable from patients with DLB on the basis of this criterion. Hallucinations, especially visual perceptions, have been reported to occur in up to 80% of patients with DLB, 8,25,26 while estimated prevalences of hallucinations in AD range from 21% to 49%. 27 Hallucinations have become a core feature in the consensus guidelines for DLB. 1 It has been reported that hallucinations were the best early predictors for the diagnosis of DLB. 13 In our study, hallucinations were present in 63% of the autopsy-proved cases of LBV and 100% of the autopsy-proved DLBD group. In contrast, hallucinations occurred in only 10% of our matched group of 20 patients with autopsyproved AD. Since only 1 of our patients misdiagnosed as having DLB who had AD pathologic findings manifested hallucinations, this would suggest that the diagnostic accuracy of DLB may be improved by placing more emphasis on hallucinations in the presence of early EPSs. An additional core feature in the consensus guidelines fluctuation in cognition has been reported to occur at any stage in up to 86% of patients with DLB. 5 Interestingly, in our study, fluctuating cognitive impairment was noted to occur only in the LBV group, with a prevalence of approximately 40% in our clinical series. No cognitive fluctuations were reported in any of the autopsyproved cases of DLBD or in the cases clinically misdiagnosed as DLB that had AD pathologic findings only. Fluctuations, however, were reported in 4 of our 20 autopsy-proved cases of AD. There are several problems with regard to the assessment of fluctuations in cognition in this and probably other studies. For instance, this entity relies heavily on opinion provided by caregivers, is poorly defined, is problematic to identify, and, in patients seen on only an annual basis, is probably difficult to remember. Repeated falls, loss of consciousness, and syncope belong to the supportive features in the consensus guidelines for the clinical diagnosis of probable or possible DLB. In this study, single or repeated falls and loss of consciousness or syncope were as prevalent in the DLB group as in the AD group and were not helpful in differentiating between cohorts. In the earlier Newcastle criteria for DLB, 5 neuroleptic sensitivity syndrome had been proposed as a mandatory sign. Later, in the consensus guidelines, this was dropped as a core characteristic but remained as a supporting feature. We did not systematically investigate neuroleptic sensitivity in our cohorts because of obvious difficulties with assessment and quantification. Recent findings indicate that severe neuroleptic sensitivity may occur in up to 30% of patients with confirmed DLB 16 ; however, none of our patients with autopsy-proved DLB had a history of neuroleptic malignant syndrome or other dramatic side effects from these compounds. 350

5 Early onset of gait impairment and tremor have also been described as prominent features of DLB. 3,7 In the present study, gait abnormalities or spontaneous parkinsonian gait and tremor, especially essential tremor, were not helpful in distinguishing between our autopsyproved DLB groups and the misdiagnosed DLB group with pure AD. Our finding that most of the misdiagnosed DLB cases had, in fact, AD pathologic findings only may be biased because we are a major referral center for AD. However, AD remains the most prevalent cause of dementia in the elderly and the most challenging entity to be differentiated from DLB. It was not the purpose of this study to investigate how often autopsy-proved DLB cases were clinically misdiagnosed as probable or possible AD. Nor did we attempt to determine clinical diagnostic accuracy for DLB at initial examination or early stages of disease. Hence, the challenge of differential diagnosis is particularly illustrative, we think, in that, for the purposes of this study, we compared the pathological diagnosis with the last recorded clinical diagnosis for each patient. Despite our access to extensive longitudinal, clinical, and neuropsychological information regarding these subjects, our diagnostic accuracy for the clinical diagnosis of DLB was poor. Since all of the patients with correctly diagnosed DLB in the current study would have met criteria for probable DLB according to consensus guidelines, placing more emphasis on hallucinations in the presence of early EPSs (thus requiring subjects to fulfill criteria for probable, not possible, DLB) is probably necessary if one hopes to improve clinical diagnostic accuracy for DLB. Further prospective clinicopathological studies are warranted and essential in this regard. Clinical diagnostic accuracy because of important neurobiological differences between DLB and AD will have major implications in terms of improving the homogeneity of subjects enrolled in therapeutic research protocols. Accepted for publication July 29, This study was supported in part by funds from the Swiss National Science Foundation, the Ciba-Geigy Jubilaeums Stiftung, and the M. & W. Lichtenstein Stiftung (U.H.), Basel, Switzerland, and by grant AGO5131 from the National Institute on Aging, Washington, DC. We gratefully acknowledge the assistance of Barbara Reader, staff members of the University of California, San Diego, Alzheimer s Disease Research Center, and Hannes B. Stähelin, MD, and Lyn Singer Lindpaintner, MD, for thoughtful comments. Reprints: Jody Corey-Bloom, MD, PhD, VA Medical Center (Mail Stop 9127), 3350 La Jolla Village Dr, San Diego, CA ( jcoreybl@vapop.ucsd.edu). REFERENCES 1. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB international workshop. Neurology. 1996;47: McKeith IG, Galasko D, Wilcock GK, Byrne EJ. Lewy body dementia: diagnosis and treatment. Br J Psychiatry. 1995;167: Hansen L, Salmon D, Galasko D, et al. The Lewy body variant of Alzheimer s disease: a clinical and pathological entity. Neurology. 1990;40: Kuzuhara S, Yoshimura M. Clinical and neuropathological aspects of diffuse Lewy body disease in the elderly. Adv Neurol. 1993;60: McKeith IG, Perry RH, Fairbairn AF, Jabeen S, Perry EK. Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med. 1992;22: McKeith IG, Fairbairn AF, Perry RH, Thompson P. The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type (SDLT). Br J Psychiatry. 1994; 165: Crystal HA, Dickson DW, Lizardi JE, Davies P, Wolfson LI. Antemortem diagnosis of diffuse Lewy body disease. Neurology. 1990;40: McKeith IG, Fairbairn AF, Bothwell RA, et al. An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology. 1994;44: Ala TA, Yang K, Sung JH, Frey WH II. Hallucinations and signs of parkinsonism help to distinguish patients with dementia and cortical Lewy bodies from patients with Alzheimer s disease at presentation: a clinicopathological study. J Neurol Neurosurg Psychiatry. 1997;62: Weiner MF, Risser RC, Cullum M, et al. Alzheimer s disease and its Lewy body variant: a clinical analysis of postmortem verified cases. Am J Psychiatry. 1996; 153: Förstl H, Burns A, Luthert P, Cairns N, Levy R. The Lewy-body variant of Alzheimer s disease: clinical and pathological findings. Br J Psychiatry. 1993;162: Kosunen O, Soininen H, Heinonen O, Talsmiemi S, Riekkinen PJ. Diagnostic accuracy of Alzheimer s disease: a neuropathological study. Acta Neuropathol (Berl). 1996;91: Litvan I, MacIntyre A, Goetz CG, et al. Accuracy of the clinical diagnosis of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol. 1998;55: Olichney JM, Galasko D, Salmon DP, et al. Cognitive decline is faster in Lewy body variant than in Alzheimer s disease. Neurology. 1998;51: Liberini P, Valerio A, Memo F, Spano PF. Lewy-body dementia and responsiveness to cholinesterase inhibitors: a paradigm for heterogeneity of Alzheimer s disease? Trends Pharmacol Sci. 1996;16: Ballard C, Grace J, McKeith I, Holmes C. Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer s disease. Lancet. 1998;351: Khatchaturian ZS. Diagnosis of Alzheimer s disease. Arch Neurol. 1985;42: Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer s Disease (CERAD), part II: standardization of the neuropathologic assessment of Alzheimer s disease. Neurology. 1991;41: Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12: Hachinski VC, Iliff LD, Zhilka E, et al. Cerebral blood flow in dementia. Arch Neurol. 1975;32: Byrne EJ, Lennox G, Lowe J, Goodwin-Austin RB. Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiatry. 1989;52: Galasko D, Katzman R, Salmon DP, Hansen L. Clinical and neuropathological finding in Lewy body dementias. Brain Cogn. 1996;31: Miller TP, Tinklenberg JR, Brooks JO III, Yesavage JA. Cognitive decline in patients with Alzheimer disease: differences in patients with and without extrapyramidal signs. Alzheimer Dis Assoc Disord. 1991;5: Stern Y, Folstein M, Albert M, et al. Multicenter study of predictors in Alzheimer s disease (the predictor study ), I: study design, cohort description and intersite comparisons. Alzheimer Dis Assoc Disord. 1993;7: Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK. Senile dementia of Lewy body type: a clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci. 1990;95: Klatka LA, Louis ED, Schiffer EB. Psychiatric features in diffuse Lewy body disease. Neurology. 1996;47: Wragg RE, Jeste DV. Overview of depression and psychosis in Alzheimer s disease. Am J Psychiatry. 1989;146:

Lewy body disease (LBD) is the second most common

Lewy body disease (LBD) is the second most common REGULAR ARTICLES Lewy Body Disease: Can We Diagnose It? Michelle Papka, Ph.D. Ana Rubio, M.D., Ph.D. Randolph B. Schiffer, M.D. Christopher Cox, Ph.D. The authors assessed the accuracy of published clinical

More information

Hallucinations and signs of parkinsonism help distinguish patients with dementia and cortical

Hallucinations and signs of parkinsonism help distinguish patients with dementia and cortical 161Journal of Neurology, Neurosurgery, and Psychiatry 1997;62:16-21 Alzheimer's Treatment and Research Center, Department of Neurology, Ramsey Clinic/Health- Partners, University of Minnesota, St Paul,

More information

ORIGINAL CONTRIBUTION. An Investigation of Clinical Correlates of Lewy Bodies in Autopsy-Proven Alzheimer Disease

ORIGINAL CONTRIBUTION. An Investigation of Clinical Correlates of Lewy Bodies in Autopsy-Proven Alzheimer Disease ORIGINAL CONTRIBUTION An Investigation of Clinical Correlates of Lewy Bodies in Autopsy-Proven Alzheimer Disease Yaakov Stern, PhD; Diane Jacobs, PhD; James Goldman, MD; Estrella Gomez-Tortosa, PhD; Bradley

More information

A prospective study of dementia with Lewy bodies

A prospective study of dementia with Lewy bodies Age and Ageing 998; 27: 6-66 998, British Geriatrics Society A prospective study of dementia with Lewy bodies CLIVE G. BALLARD, JOHN O'BRIEN, KATH LOWERX GARETH A. AYRE, RICHARD HARRISON, ROBERT PERRY,

More information

ORIGINAL CONTRIBUTION. Diagnostic Validity of the Dementia Questionnaire for Alzheimer Disease

ORIGINAL CONTRIBUTION. Diagnostic Validity of the Dementia Questionnaire for Alzheimer Disease ORIGINAL CONTRIBUTION Diagnostic Validity of the Dementia Questionnaire for Alzheimer Disease Ronald J. Ellis, MD, PhD; Kaining Jan, MD; Claudia Kawas, MD; William C. Koller, MD; Kelly E. Lyons, PhD; Dilip

More information

Predicting Lewy Body Pathology in a Community-Based Sample With Clinical Diagnosis of Alzheimer s Disease

Predicting Lewy Body Pathology in a Community-Based Sample With Clinical Diagnosis of Alzheimer s Disease Predicting Lewy Body Pathology in a Community-Based Sample With Clinical Diagnosis of Alzheimer s Disease Debby Tsuang, MD, MSc, Kate Simpson, MPH, Eric B. Larson, MD, MPH, Elaine Peskind, MD, Walter Kukull,

More information

ORIGINAL ARTICLE. Early and Widespread Cholinergic Losses Differentiate Dementia With Lewy Bodies From Alzheimer Disease

ORIGINAL ARTICLE. Early and Widespread Cholinergic Losses Differentiate Dementia With Lewy Bodies From Alzheimer Disease ORIGINAL ARTICLE Early and Widespread Cholinergic Losses Differentiate Dementia With Lewy Bodies From Alzheimer Disease Pietro Tiraboschi, MD; Larry A. Hansen, MD; Michael Alford, BA; Annette Merdes, MD;

More information

Pentagon copying is more impaired in dementia with Lewy bodies than in Alzheimer s disease

Pentagon copying is more impaired in dementia with Lewy bodies than in Alzheimer s disease J Neurol Neurosurg Psychiatry 2001;70:483 488 483 Center for Alzheimer Disease and Related Disorders, Department of Neurology, Southern Illinois University School of Medicine, Springfield, Illinois, USA

More information

ORIGINAL CONTRIBUTION. The Progression of Cognition, Psychiatric Symptoms, and Functional Abilities in Dementia With Lewy Bodies and Alzheimer Disease

ORIGINAL CONTRIBUTION. The Progression of Cognition, Psychiatric Symptoms, and Functional Abilities in Dementia With Lewy Bodies and Alzheimer Disease ORIGINAL CONTRIBUTION The Progression of Cognition, Psychiatric Symptoms, and Functional Abilities in Dementia With Lewy Bodies and Alzheimer Disease Karina Stavitsky, BS; Adam M. Brickman, PhD; Nikolaos

More information

Baseline Characteristics of Patients Attending the Memory Clinic Serving the South Shore of Boston

Baseline Characteristics of Patients Attending the   Memory Clinic Serving the South Shore of Boston Article ID: ISSN 2046-1690 Baseline Characteristics of Patients Attending the www.thealzcenter.org Memory Clinic Serving the South Shore of Boston Corresponding Author: Dr. Anil K Nair, Chief of Neurology,

More information

Neuropathological Substrates of Psychiatric Symptoms in Prospectively Studied Patients With Autopsy- Confirmed Dementia With Lewy Bodies

Neuropathological Substrates of Psychiatric Symptoms in Prospectively Studied Patients With Autopsy- Confirmed Dementia With Lewy Bodies Article Neuropathological Substrates of Psychiatric Symptoms in Prospectively Studied Patients With Autopsy- Confirmed Dementia With Lewy Bodies Clive G. Ballard, M.R.C.Psych., M.D. Robin Jacoby, F.R.C.Psych.,

More information

ORIGINAL CONTRIBUTION. Accuracy of the Clinical Diagnoses of Lewy Body Disease, Parkinson Disease, and Dementia With Lewy Bodies

ORIGINAL CONTRIBUTION. Accuracy of the Clinical Diagnoses of Lewy Body Disease, Parkinson Disease, and Dementia With Lewy Bodies Accuracy of the Clinical Diagnoses of Lewy Body Disease, Parkinson Disease, and Dementia With Lewy Bodies A Clinicopathologic Study ORIGINAL CONTRIBUTION I. Litvan, MD; A. MacIntyre, MHS; C. G. Goetz,

More information

ORIGINAL CONTRIBUTION. Attention and Fluctuating Attention in Patients With Dementia With Lewy Bodies and Alzheimer Disease

ORIGINAL CONTRIBUTION. Attention and Fluctuating Attention in Patients With Dementia With Lewy Bodies and Alzheimer Disease ORIGINAL CONTRIBUTION Attention and Fluctuating Attention in Patients With Dementia With Lewy Bodies and Alzheimer Disease Clive Ballard, MRCPsych, MD; John O Brien, MRCPsych, DM; Alistair Gray, BSc; Franchesca

More information

Frontotemporal dementia and dementia with Lewy bodies in a case-control study of Alzheimer s disease

Frontotemporal dementia and dementia with Lewy bodies in a case-control study of Alzheimer s disease International Psychogeriatrics: page 1 of 8 C 2009 International Psychogeriatric Association doi:10.1017/s1041610209009454 Frontotemporal dementia and dementia with Lewy bodies in a case-control study

More information

Visual Hallucinations in Dementia: A Prospective Community-Based Study With Autopsy

Visual Hallucinations in Dementia: A Prospective Community-Based Study With Autopsy Visual Hallucinations in Dementia: A Prospective Community-Based Study With Autopsy Debby Tsuang, M.D., M.Sc., Eric B. Larson, M.D., M.P.H., Elizabeth Bolen, B.S., Mary Lou Thompson, Ph.D., Elaine Peskind,

More information

Hallucinations, delusions, and cognitive decline in Alzheimer s disease

Hallucinations, delusions, and cognitive decline in Alzheimer s disease 172 Department of Neurological Sciences, Rush Alzheimer s Disease Center and Rush Institute for Healthy Aging, 1645 West Jackson Boulevard, Suite 675, Chicago, Illinois 60612, USA R S Wilson D W Gilley

More information

Predictors of disease course in patients with probable Alzheimer's disease

Predictors of disease course in patients with probable Alzheimer's disease Article abstract-the presence of extrapyramidal signs or psychosis may indicate greater disability in patients with probable Alzheimer's disease. We evaluated the ability of these signs, noted at a patient's

More information

Extrapyramidal features in Alzheimer s disease

Extrapyramidal features in Alzheimer s disease Age and Ageing 1999; 28: 401 409 1999, British Geriatrics Society REVIEW Extrapyramidal features in Alzheimer s disease SUSAN L. MITCHELL Faculty of Medicine, University of Ottawa and Division of Geriatric

More information

ORIGINAL CONTRIBUTION. Cognitive Profiles of Autopsy-Confirmed Lewy Body Variant vs Pure Alzheimer Disease

ORIGINAL CONTRIBUTION. Cognitive Profiles of Autopsy-Confirmed Lewy Body Variant vs Pure Alzheimer Disease ORIGINAL CONTRIBUTION Cognitive Profiles of Autopsy-Confirmed Lewy Body Variant vs Pure Alzheimer Disease Donald J. Connor, PhD; David P. Salmon, PhD; Teresa J. Sandy, BS; Douglas Galasko, MD; Lawrence

More information

T he prevalence of Parkinson s disease (PD) is nearly 1% in

T he prevalence of Parkinson s disease (PD) is nearly 1% in 708 PAPER Donepezil for cognitive impairment in Parkinson s disease: a randomised controlled study D Aarsland, K Laake, J P Larsen, C Janvin... See end of article for authors affiliations... Correspondence

More information

Parkinsonian Disorders with Dementia

Parkinsonian Disorders with Dementia Parkinsonian Disorders with Dementia George Tadros Consultant in Old Age Liaison Psychiatry, RAID, Heartlands Hospital Professor of Dementia and Liaison Psychiatry, Aston Medical School Aston University

More information

Clinical features of dementia with lewy bodies in 35 Chinese patients

Clinical features of dementia with lewy bodies in 35 Chinese patients Han et al. Translational Neurodegeneration 2014, 3:1 Translational Neurodegeneration RESEARCH Open Access Clinical features of dementia with lewy bodies in 35 Chinese patients Ding Han, Qiong Wang, Zhongbao

More information

Dementia. Stephen S. Flitman, MD Medical Director 21st Century Neurology

Dementia. Stephen S. Flitman, MD Medical Director 21st Century Neurology Dementia Stephen S. Flitman, MD Medical Director 21st Century Neurology www.neurozone.org Dementia is a syndrome Progressive memory loss, plus Progressive loss of one or more cognitive functions: Language

More information

C linicians have noted a close association between. Lewy body cortical involvement may not always predict dementia in Parkinson s disease PAPER

C linicians have noted a close association between. Lewy body cortical involvement may not always predict dementia in Parkinson s disease PAPER 852 PAPER Lewy body cortical involvement may not always predict dementia in Parkinson s disease C Colosimo, A J Hughes, L Kilford, A J Lees... See end of article for authors affiliations... Correspondence

More information

Validity of Family History for the Diagnosis of Dementia Among Siblings of Patients With Late-onset Alzheimer s Disease

Validity of Family History for the Diagnosis of Dementia Among Siblings of Patients With Late-onset Alzheimer s Disease Genetic Epidemiology 15:215 223 (1998) Validity of Family History for the Diagnosis of Dementia Among Siblings of Patients With Late-onset Alzheimer s Disease G. Devi, 1,3 * K. Marder, 1,3 P.W. Schofield,

More information

What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia

What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia Dementia: broad term for any acquired brain condition impairing mental function such that ADLs are impaired. Includes:

More information

Improving diagnosis of Alzheimer s disease and lewy body dementia. Brain TLC October 2018

Improving diagnosis of Alzheimer s disease and lewy body dementia. Brain TLC October 2018 Improving diagnosis of Alzheimer s disease and lewy body dementia Brain TLC October 2018 Plan for this discussion: Introduction to AD and LBD Why do we need to improve diagnosis? What progress has been

More information

Clinical Diagnosis. Step 1: Dementia or not? Diagnostic criteria for dementia (DSM-IV)

Clinical Diagnosis. Step 1: Dementia or not? Diagnostic criteria for dementia (DSM-IV) Step 1: Dementia or not? Diagnostic criteria for dementia (DSM-IV) A. The development of multiple cognitive deficits manifested by both 1 and 2 1 1. Memory impairment 2. One (or more) of the following

More information

The Spectrum of Lewy Body Disease: Dementia with Lewy Bodies and Parkinson's Disease Dementia

The Spectrum of Lewy Body Disease: Dementia with Lewy Bodies and Parkinson's Disease Dementia Disclosures Research support, Parkinson Society Canada, Canadian Institutes of Health Research, Ministry of Economic Development and Innovation, Teva Novartis clinical trial, Principal Investigator CME

More information

DIFFERENTIAL DIAGNOSIS SARAH MARRINAN

DIFFERENTIAL DIAGNOSIS SARAH MARRINAN Parkinson s Academy Registrar Masterclass Sheffield DIFFERENTIAL DIAGNOSIS SARAH MARRINAN 17 th September 2014 Objectives Importance of age in diagnosis Diagnostic challenges Brain Bank criteria Differential

More information

The efficacy of Rivastigmine in the management of the behavioral and psychological symptoms of lewy body dementia- a review of literature

The efficacy of Rivastigmine in the management of the behavioral and psychological symptoms of lewy body dementia- a review of literature Review article: The efficacy of Rivastigmine in the management of the behavioral and psychological symptoms of lewy body dementia- a review of literature Dr. Ivan Netto 1, Aditya Iyer 2, Dr. Prathamesh

More information

ORIGINAL CONTRIBUTION. Visuoperceptual Impairment in Dementia With Lewy Bodies

ORIGINAL CONTRIBUTION. Visuoperceptual Impairment in Dementia With Lewy Bodies ORIGINAL CONTRIBUTION Visuoperceptual Impairment in Dementia With Lewy Bodies Etsuro Mori, MD, PhD; Tatsuo Shimomura, MD; Misato Fujimori, PhD; Nobutsugu Hirono, MD, PhD; Toru Imamura, MD, PhD; Mamoru

More information

Neuropsychiatric Symptoms of Patients With Progressive Supranuclear Palsy and Parkinson s Disease

Neuropsychiatric Symptoms of Patients With Progressive Supranuclear Palsy and Parkinson s Disease Neuropsychiatric Symptoms of Patients With Progressive Supranuclear Palsy and Parkinson s Disease Dag Aarsland, M.D., Ph.D. Irene Litvan, M.D. Jan P. Larsen, M.D., Ph.D. Neuropsychiatric symptoms are common

More information

ORIGINAL CONTRIBUTION. Apolipoprotein E 4 Is a Determinant for Alzheimer-Type Pathologic Features in Tauopathies, Synucleinopathies,

ORIGINAL CONTRIBUTION. Apolipoprotein E 4 Is a Determinant for Alzheimer-Type Pathologic Features in Tauopathies, Synucleinopathies, ORIGINAL CONTRIBUTION Apolipoprotein E 4 Is a Determinant for Alzheimer-Type Pathologic Features in Tauopathies, Synucleinopathies, and Frontotemporal Degeneration Keith A. Josephs, MST, MD; Yoshio Tsuboi,

More information

UDS Progress Report. -Standardization and Training Meeting 11/18/05, Chicago. -Data Managers Meeting 1/20/06, Chicago

UDS Progress Report. -Standardization and Training Meeting 11/18/05, Chicago. -Data Managers Meeting 1/20/06, Chicago UDS Progress Report -Standardization and Training Meeting 11/18/05, Chicago -Data Managers Meeting 1/20/06, Chicago -Training material available: Gold standard UDS informant and participant interviews

More information

Alzheimer Disease & Associated Disorders - An International Journal Spongiform Change in Dementia with Lewy Bodies and Alzheimer's Disease

Alzheimer Disease & Associated Disorders - An International Journal Spongiform Change in Dementia with Lewy Bodies and Alzheimer's Disease Alzheimer Disease & Associated Disorders - An International Journal Spongiform Change in Dementia with Lewy Bodies and Alzheimer's Disease --Manuscript Draft-- Manuscript Number: Full Title: Article Type:

More information

Parkinson Disease. Lorraine Kalia, MD, PhD, FRCPC. Presented by: Ontario s Geriatric Steering Committee

Parkinson Disease. Lorraine Kalia, MD, PhD, FRCPC. Presented by: Ontario s Geriatric Steering Committee Parkinson Disease Lorraine Kalia, MD, PhD, FRCPC Key Learnings Parkinson Disease (L. Kalia) Key Learnings Parkinson disease is the most common but not the only cause of parkinsonism Parkinson disease is

More information

Neuropsychological profile of dementia with Lewy bodiespsy_283

Neuropsychological profile of dementia with Lewy bodiespsy_283 85..90 doi:10.1111/j.1479-8301.2009.00283.x PSYCHOGERIATRICS 2009; 9: 85 90 REVIEW ARTICLE Neuropsychological profile of dementia with Lewy bodiespsy_283 Haruhiko ODA, Yasuji YAMAMOTO and Kiyoshi MAEDA

More information

Dementia and Healthy Ageing : is the pathology any different?

Dementia and Healthy Ageing : is the pathology any different? Dementia and Healthy Ageing : is the pathology any different? Professor David Mann, Professor of Neuropathology, University of Manchester, Hope Hospital, Salford DEMENTIA Loss of connectivity within association

More information

Revised criteria for the clinical diagnosis of dementia with Lewy. Dementia with Lewy bodies. (Dementia with Lewy Bodies)

Revised criteria for the clinical diagnosis of dementia with Lewy. Dementia with Lewy bodies. (Dementia with Lewy Bodies) Dementia with Lewy bodies First described: Okazaki H, 1961, Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion. J Neuropathol Exp

More information

Parkinson's diseases. dementia: companson with Alzheimer's and. Motor and cognitive function in Lewy body. of patients with Lewy body dementia

Parkinson's diseases. dementia: companson with Alzheimer's and. Motor and cognitive function in Lewy body. of patients with Lewy body dementia J7ournal of Neurology, Neurosurgery, and Psychiatry 1997;62:243-252 Department of Old Age Psychiatry K K Gnanalingham E Byrne A Thornton Department of Neurology, Withington Hospital, Nell lane, West Didsbury,

More information

UDS version 3 Summary of major changes to UDS form packets

UDS version 3 Summary of major changes to UDS form packets UDS version 3 Summary of major changes to UDS form packets from version 2 to VERSION 3 february 18 final Form A1: Subject demographics Updated question on principal referral source to add additional options

More information

10/30/2018. How do we diagnose dementia? Subtypes of dementia Case Studies

10/30/2018. How do we diagnose dementia? Subtypes of dementia Case Studies http://www.alz.org/alzheimers_disease_10_signs_of_alzheimers.asp#signs How do we diagnose dementia? Subtypes of dementia Case Studies 1. Memory loss that disrupts daily life Forgetting important dates

More information

Dementia With Lewy Bodies: A Review Of Clinical Diagnosis, Neuropathology And Management Options Tanis J. Ferman, Ph.D.

Dementia With Lewy Bodies: A Review Of Clinical Diagnosis, Neuropathology And Management Options Tanis J. Ferman, Ph.D. Dementia With Lewy Bodies: A Review Of Clinical Diagnosis, Neuropathology And Management Options Tanis J. Ferman, Ph.D. Table 1. Core And Supportive Features For The Clinical Diagnosis Of DLB. 13 1. The

More information

ORIGINAL CONTRIBUTION. Delusions and Hallucinations Are Associated With Worse Outcome in Alzheimer Disease

ORIGINAL CONTRIBUTION. Delusions and Hallucinations Are Associated With Worse Outcome in Alzheimer Disease ORIGINAL CONTRIBUTION Delusions and Hallucinations Are Associated With Worse Outcome in Alzheimer Disease Nikolaos Scarmeas, MD; Jason Brandt, PhD; Marilyn Albert, PhD; Georgios Hadjigeorgiou, MD; Alexandros

More information

Enhanced Primary Care Pathway: Parkinson s Disease

Enhanced Primary Care Pathway: Parkinson s Disease Enhanced Primary Care Pathway: Parkinson s Disease 1. Focused summary of PD relevant to primary care Parkinson s Disease (PD) and Essential tremor (ET) are two of the most common movement disorders encountered

More information

Dementia Past, Present and Future

Dementia Past, Present and Future Dementia Past, Present and Future Morris Freedman MD, FRCPC Division of Neurology Baycrest and University of Toronto Rotman Research Institute, Baycrest CNSF 2015 Objectives By the end of this presentation,

More information

Clinicopathologic and genetic aspects of hippocampal sclerosis. Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA

Clinicopathologic and genetic aspects of hippocampal sclerosis. Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA Clinicopathologic and genetic aspects of hippocampal sclerosis Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA The hippocampus in health & disease A major structure of the medial temporal

More information

Ruolo dei biomarcatori come criterio di supporto nella diagnostica delle demenze ad esordio precoce

Ruolo dei biomarcatori come criterio di supporto nella diagnostica delle demenze ad esordio precoce Ruolo dei biomarcatori come criterio di supporto nella diagnostica delle demenze ad esordio precoce ALESSANDRO MARTORANA UOC NEUROLOGIA-CENTRO ALZHEIMER POLICLINICO TOR VERGATA-UNIVERSITÀ DI ROMA TOR VERGATA

More information

doi: /brain/aws234 Brain 2012: 135;

doi: /brain/aws234 Brain 2012: 135; doi:10.1093/brain/aws234 Brain 2012: 135; 3005 3014 3005 BRAIN A JOURNAL OF NEUROLOGY Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies J. A. Schneider,

More information

ORIGINAL CONTRIBUTION

ORIGINAL CONTRIBUTION ORIGINAL CONTRIBUTION Common Misdiagnosis of a Common Neurological Disorder How Are We Misdiagnosing Essential Tremor? Samay Jain, MD; Steven E. Lo, MD; Elan D. Louis, MD, MS Background: As a common neurological

More information

ORIGINAL CONTRIBUTION. Regional Distribution of Neuritic Plaques in the Nondemented Elderly and Subjects With Very Mild Alzheimer Disease

ORIGINAL CONTRIBUTION. Regional Distribution of Neuritic Plaques in the Nondemented Elderly and Subjects With Very Mild Alzheimer Disease ORIGINAL CONTRIBUTION Regional Distribution of Neuritic Plaques in the Nondemented Elderly and Subjects With Very Mild Alzheimer Disease Vahram Haroutunian, PhD; Daniel P. Perl, MD; Dushyant P. Purohit,

More information

Caring Sheet #11: Alzheimer s Disease:

Caring Sheet #11: Alzheimer s Disease: CARING SHEETS: Caring Sheet #11: Alzheimer s Disease: A Summary of Information and Intervention Suggestions with an Emphasis on Cognition By Shelly E. Weaverdyck, PhD Introduction This caring sheet focuses

More information

Comparison of cognitive decline between dementia with Lewy bodies and Alzheimer s disease: a cohort study

Comparison of cognitive decline between dementia with Lewy bodies and Alzheimer s disease: a cohort study Open Access To cite: Walker Z, McKeith I, Rodda J, et al. Comparison of cognitive decline between dementia with Lewy bodies and Alzheimer s disease: a cohort study. BMJ Open 2012;2:e000380. doi:10.1136/

More information

III./3.1. Movement disorders with akinetic rigid symptoms

III./3.1. Movement disorders with akinetic rigid symptoms III./3.1. Movement disorders with akinetic rigid symptoms III./3.1.1. Parkinson s disease Parkinson s disease (PD) is the second most common neurodegenerative disorder worldwide after Alzheimer s disease.

More information

Update on functional brain imaging in Movement Disorders

Update on functional brain imaging in Movement Disorders Update on functional brain imaging in Movement Disorders Mario Masellis, MSc, MD, FRCPC, PhD Assistant Professor & Clinician-Scientist Sunnybrook Health Sciences Centre University of Toronto 53 rd CNSF

More information

C holinomimetic drugs constitute the first line of treatment

C holinomimetic drugs constitute the first line of treatment 310 PAPER Cholinesterase inhibitor treatment alters the natural history of Alzheimer s disease O L Lopez, J T Becker, S Wisniewski, J Saxton, D I Kaufer, S T DeKosky... See end of article for authors affiliations...

More information

Dementia Update. October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada

Dementia Update. October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada Dementia Update October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada Outline New concepts in Alzheimer disease Biomarkers and in vivo diagnosis Future trends

More information

Behavioral and Psychologic Symptoms in Different Types of Dementia

Behavioral and Psychologic Symptoms in Different Types of Dementia ORIGINAL ARTICLE Behavioral and Psychologic Symptoms in Different Types of Dementia Ming-Jang Chiu,* Ta-Fu Chen, Ping-Keung Yip, Mau-Sun Hua, 1 Li-Yu Tang 2 Background/Purpose: Behavioral and psychologic

More information

Differential Diagnosis of Hypokinetic Movement Disorders

Differential Diagnosis of Hypokinetic Movement Disorders Differential Diagnosis of Hypokinetic Movement Disorders Dr Donald Grosset Consultant Neurologist - Honorary Professor Institute of Neurological Sciences - Glasgow University Hypokinetic Parkinson's Disease

More information

Date of Referral: Enhanced Primary Care Pathway: Parkinson s Disease

Date of Referral: Enhanced Primary Care Pathway: Parkinson s Disease Specialist LINK Linking Physicians CALGARY AND AREA Patient Name: Date of Birth: Calgary RHRN: PHN / ULI: Date of Referral: Referring MD: Fax: Today s Date: CONFIRMATION: TRIAGE CATEGORY: REFERRAL STATUS:

More information

Dementia. Aetiology, pathophysiology and the role of neuropsychological testing. Dr Sheng Ling Low Geriatrician

Dementia. Aetiology, pathophysiology and the role of neuropsychological testing. Dr Sheng Ling Low Geriatrician Dementia Aetiology, pathophysiology and the role of neuropsychological testing Dr Sheng Ling Low Geriatrician Topics to cover Why is dementia important What is dementia Differentiate between dementia,

More information

Age, Neuropathology, and Dementia

Age, Neuropathology, and Dementia The new england journal of medicine original article Age, Neuropathology, and Dementia George M. Savva, Ph.D., Stephen B. Wharton, F.R.C.Path., Paul G. Ince, M.D., Gillian Forster, B.Sc., Fiona E. Matthews,

More information

Psychosis and Agitation in Dementia

Psychosis and Agitation in Dementia Psychosis and Agitation in Dementia Dilip V. Jeste, MD Estelle & Edgar Levi Chair in Aging, Director, Stein Institute for Research on Aging, Distinguished Professor of Psychiatry & Neurosciences, University

More information

Cognitive Decline in Patients with Alzheimer's Disease, Vascular Dementia and Senile Dementia of Lewy Body Type

Cognitive Decline in Patients with Alzheimer's Disease, Vascular Dementia and Senile Dementia of Lewy Body Type Age and Ageing 1996.25:209-21 3 Cognitive Decline in atients with Alzheimer's Disease, Vascular Dementia and Senile Dementia of Lewy Body Type C. BALLARD, A. ATEL, F. OYEBODE, G. WILCOCK Summary One hundred

More information

Clinical Features and Treatment of Parkinson s Disease

Clinical Features and Treatment of Parkinson s Disease Clinical Features and Treatment of Parkinson s Disease Richard Camicioli, MD, FRCPC Cognitive and Movement Disorders Department of Medicine University of Alberta 1 Objectives To review the diagnosis and

More information

NIH Public Access Author Manuscript Mov Disord. Author manuscript; available in PMC 2009 May 18.

NIH Public Access Author Manuscript Mov Disord. Author manuscript; available in PMC 2009 May 18. NIH Public Access Author Manuscript Published in final edited form as: Mov Disord. 2008 August 15; 23(11): 1602 1605. doi:10.1002/mds.22161. Emergence of Parkinsons Disease in Essential Tremor: A Study

More information

Non Alzheimer Dementias

Non Alzheimer Dementias Non Alzheimer Dementias Randolph B Schiffer Department of Neuropsychiatry and Behavioral Science Texas Tech University Health Sciences Center 9/11/2007 Statement of Financial Disclosure Randolph B Schiffer,,

More information

Ian McKeith MD, F Med Sci, Professor of Old Age Psychiatry, Newcastle University

Ian McKeith MD, F Med Sci, Professor of Old Age Psychiatry, Newcastle University Ian McKeith MD, F Med Sci, Professor of Old Age Psychiatry, Newcastle University Design of trials in DLB and PDD What has been learnt from previous trials in these indications and other dementias? Overview

More information

Dementia. Dr Maria Foundas Consultant Physician. Training support Skills development Competency Assessment Scholarships Education

Dementia. Dr Maria Foundas Consultant Physician. Training support Skills development Competency Assessment Scholarships Education Dementia Dr Maria Foundas Consultant Physician Training support Skills development Competency Assessment Scholarships Education Preamble and disclaimer These slides are made available by the Western Australian

More information

LU:research Institutional Repository of Lund University

LU:research Institutional Repository of Lund University LU:research Institutional Repository of Lund University This is an author produced version of a paper published in International journal of geriatric psychiatry. This paper has been peer-reviewed but does

More information

ORIGINAL CONTRIBUTION. Neurofibrillary Tangles in Nondemented Elderly Subjects and Mild Alzheimer Disease

ORIGINAL CONTRIBUTION. Neurofibrillary Tangles in Nondemented Elderly Subjects and Mild Alzheimer Disease ORIGINAL CONTRIBUTION Neurofibrillary Tangles in Nondemented Elderly Subjects and Mild Alzheimer Disease Vahram Haroutunian, PhD; Dushyant P. Purohit, MD; Daniel P. Perl, MD; Deborah Marin, MD; Khalid

More information

How to Diagnose Early (Prodromal) Lewy Body Dementia. Ian McKeith MD, FRCPsych, F Med Sci.

How to Diagnose Early (Prodromal) Lewy Body Dementia. Ian McKeith MD, FRCPsych, F Med Sci. How to Diagnose Early (Prodromal) Lewy Body Dementia Ian McKeith MD, FRCPsych, F Med Sci. Parkinson s Disease Lewy Body Disease Time PD Dementia Lewy Body Dementias Dementia with Lewy Bodies (DLB) Diagnostic

More information

The Long-term Prognosis of Delirium

The Long-term Prognosis of Delirium The Long-term Prognosis of Jane McCusker, MD, DrPH, Professor, Epidemiology and Biostatistics, McGill University; Head, Clinical Epidemiology and Community Studies, St. Mary s Hospital, Montreal, QC. Nine

More information

Clinical Differences Among Four Common Dementia Syndromes. a program of Morningside Ministries

Clinical Differences Among Four Common Dementia Syndromes. a program of Morningside Ministries Clinical Differences Among Four Common Dementia Syndromes a program of Morningside Ministries Introduction Four clinical dementia syndromes account for 90% of all cases after excluding reversible causes

More information

Drugs for dementia: the first year

Drugs for dementia: the first year The Ulster Medical Journal, Volume 69, No. 2, pp. 123-127, November 2000. Drugs for dementia: the first year An audit of prescribing practice G McGirr, S A Compton Accepted 12 September 2000 SUMMARY In

More information

ORIGINAL CONTRIBUTION. Cerebrospinal Fluid -Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic

ORIGINAL CONTRIBUTION. Cerebrospinal Fluid -Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic ORIGINAL CONTRIBUTION Cerebrospinal Fluid -Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain Tero Tapiola, MD, PhD; Irina Alafuzoff, MD, PhD; Sanna-Kaisa Herukka,

More information

ORIGINAL CONTRIBUTION. Functional Correlates and Prevalence of Mild Parkinsonian Signs in a Community Population of Older People

ORIGINAL CONTRIBUTION. Functional Correlates and Prevalence of Mild Parkinsonian Signs in a Community Population of Older People ORIGINAL CONTRIBUTION Functional Correlates and Prevalence of Mild Parkinsonian Signs in a Community Population of Older People Elan D. Louis, MS, MD; Ming X. Tang, PhD; Nicole Schupf, PhD; Richard Mayeux,

More information

The course of neuropsychiatric symptoms in dementia. Part II: relationships among behavioural sub-syndromes and the influence of clinical variables

The course of neuropsychiatric symptoms in dementia. Part II: relationships among behavioural sub-syndromes and the influence of clinical variables INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY Int J Geriatr Psychiatry 2005; 20: 531 536. Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/gps.1317 The course of neuropsychiatric

More information

Dementia is a common neuropsychiatric disorder characterized by progressive impairment of

Dementia is a common neuropsychiatric disorder characterized by progressive impairment of Focused Issue of This Month Diagnosis and Treatment for Behavioral and Psychological Symptoms of Dementia Byoung Hoon Oh, MD Department of Psychiatry, Yonsei University College of Medicine E - mail : drobh@yuhs.ac

More information

Anosognosia, or loss of insight into one s cognitive

Anosognosia, or loss of insight into one s cognitive REGULAR ARTICLES Anosognosia Is a Significant Predictor of Apathy in Alzheimer s Disease Sergio E. Starkstein, M.D., Ph.D. Simone Brockman, M.A. David Bruce, M.D. Gustavo Petracca, M.D. Anosognosia and

More information

Neuropathology of Neurodegenerative Disorders Prof. Jillian Kril

Neuropathology of Neurodegenerative Disorders Prof. Jillian Kril Neurodegenerative disorders to be discussed Alzheimer s disease Lewy body diseases Frontotemporal dementia and other tauopathies Huntington s disease Motor Neuron Disease 2 Neuropathology of neurodegeneration

More information

Evaluation of the NINCDS-ADRDA criteria in the diverentiation of Alzheimer s disease and frontotemporal dementia

Evaluation of the NINCDS-ADRDA criteria in the diverentiation of Alzheimer s disease and frontotemporal dementia 184 Neurology A R Varma J S Snowden P R Talbot D Neary Medical Physics, Manchester Royal Infirmary, Manchester, UK J J Lloyd Pathological Sciences, Manchester Medical School, Manchester, UK D M A Mann

More information

7/3/2013 ABNORMAL PSYCHOLOGY SEVENTH EDITION CHAPTER FOURTEEN CHAPTER OUTLINE. Dementia, Delirium, and Amnestic Disorders. Oltmanns and Emery

7/3/2013 ABNORMAL PSYCHOLOGY SEVENTH EDITION CHAPTER FOURTEEN CHAPTER OUTLINE. Dementia, Delirium, and Amnestic Disorders. Oltmanns and Emery ABNORMAL PSYCHOLOGY SEVENTH EDITION Oltmanns and Emery PowerPoint Presentations Prepared by: Ashlea R. Smith, Ph.D. This multimedia and its contents are protected under copyright law. The following are

More information

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. Introduction. Parkinson's disease (PD) has been considered largely as a motor disorder. It has been increasingly recognized that

More information

Recognition of Alzheimer s Disease: the 7 Minute Screen

Recognition of Alzheimer s Disease: the 7 Minute Screen 265 Recognition of Alzheimer s Disease: the 7 Minute Screen Paul R. Solomon, PhD; William W. Pendlebury, MD Background and Objectives: Because Alzheimer s disease (AD) tends to be underdiagnosed, we developed

More information

ALZHEIMER S DISEASE. Mary-Letitia Timiras M.D. Overlook Hospital Summit, New Jersey

ALZHEIMER S DISEASE. Mary-Letitia Timiras M.D. Overlook Hospital Summit, New Jersey ALZHEIMER S DISEASE Mary-Letitia Timiras M.D. Overlook Hospital Summit, New Jersey Topics Covered Demography Clinical manifestations Pathophysiology Diagnosis Treatment Future trends Prevalence and Impact

More information

NEUROPSYCHOMETRIC TESTS

NEUROPSYCHOMETRIC TESTS NEUROPSYCHOMETRIC TESTS CAMCOG It is the Cognitive section of Cambridge Examination for Mental Disorders of the Elderly (CAMDEX) The measure assesses orientation, language, memory, praxis, attention, abstract

More information

ACENTRAL TENET OF ALZHEIMER

ACENTRAL TENET OF ALZHEIMER CLINICAL INVESTIGATION Cholinergic Markers in Elderly Patients With Early Signs of Alzheimer Disease Kenneth L. Davis, MD Richard C. Mohs, PhD Deborah Marin, MD Dushyant P. Purohit, MD Daniel P. Perl,

More information

ORIGINAL CONTRIBUTION. The Relative Frequency of Dementia of Unknown Etiology Increases With Age and Is Nearly 50% in Nonagenarians

ORIGINAL CONTRIBUTION. The Relative Frequency of Dementia of Unknown Etiology Increases With Age and Is Nearly 50% in Nonagenarians ORIGINAL CONTRIBUTION The Relative Frequency of Dementia of Unknown Etiology Increases With Age and Is Nearly 50% in Nonagenarians Howard A. Crystal, MD; Dennis Dickson, MD; Peter Davies, PhD; David Masur,

More information

Original Article Limbic Lobe Microvacuolation is Minimal in Alzheimer s Disease in the Absence of Concurrent Lewy Body Disease

Original Article Limbic Lobe Microvacuolation is Minimal in Alzheimer s Disease in the Absence of Concurrent Lewy Body Disease www.ijcep.com/ijcep709002 Original Article Limbic Lobe Microvacuolation is Minimal in Alzheimer s Disease in the Absence of Concurrent Lewy Body Disease Yasuhiro Fujino and Dennis W. Dickson Neuropathology

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Dopamine Transporter Imaging with Single Photon Emission File Name: Origination: Last CAP Review: Next CAP Review: Last Review: dopamine_transporter_imaging_with_single_photon_emission_computed_tomography

More information

Neuropsychiatric disturbances such as delusions,

Neuropsychiatric disturbances such as delusions, Differential Neuropsychiatric Responses to Tacrine in Alzheimer s Disease: Relationship to Dementia Severity Daniel Kaufer, M.D. Jeffrey L. Cummings, M.D. Dianne Christine, R.N. Neuropsychiatric symptom

More information

Neuropsychological Evaluation of

Neuropsychological Evaluation of Neuropsychological Evaluation of Alzheimer s Disease Joanne M. Hamilton, Ph.D. Shiley-Marcos Alzheimer s Disease Research Center Department of Neurosciences University of California, San Diego Establish

More information

Dementia with Lewy Bodies. A Distinct Non-Alzheimer Dementia Syndrome?

Dementia with Lewy Bodies. A Distinct Non-Alzheimer Dementia Syndrome? Brain Pathology 8: 299-324(1998) Dementia with Lewy Bodies. A Distinct Non-Alzheimer Dementia Syndrome? Paul G. Ince 1, 2, Elaine K. Perry 1, Chris. M. Morris 1 MRC Neurochemical Pathology Unit 1, University

More information

17 th WORKSHOP ON NEUROOTOLOGY. Dementia & Imbalance. DR. ATRI CHATTERJEE Assistant Professor. Neurology VMMC & SafdarJung Hospital New Delhi

17 th WORKSHOP ON NEUROOTOLOGY. Dementia & Imbalance. DR. ATRI CHATTERJEE Assistant Professor. Neurology VMMC & SafdarJung Hospital New Delhi 17 th WORKSHOP ON NEUROOTOLOGY Dementia & Imbalance DR. ATRI CHATTERJEE Assistant Professor. Neurology VMMC & SafdarJung Hospital New Delhi ?Association Dementia Imbalance?Causation balance: An even distribution

More information